Breast Cancer 2020
Breast cancer conferences provide a great opportunity for the researchers worldwide to share their knowledge at a global platform. By gathering expert speakers and leading professionals and providing them with strategic knowledge and growth opportunities in the field of breast cancer research. Genoteq Healthcare organizes scientific conferences every year at international level. This conference helps in sharing innovations through oral, poster, e-poster presentation. Along with new innovations for treatment and diagnosis, it also envisages for bringing out breast cancer research for a sustainable treatment and diagnosis worldwide. The intending participants can confirm their participants by registering for the conference under the theme “Creating awareness and discussion of present scenario of breast cancer “along with your colleagues.
Breast cancer conference is a premier event which is organized to provide a global platform to share the latest advancements in Breast cancer research. Cancer that arises from breast tissue is known as breast cancer. Breast cancer mostly develops from the cells lining of milk ducts and lobules that supply the ducts with milk. Cancers that develop from the ducts are called as ductal carcinomas. Breast cancer is the commonly seen in women and also affect men too.
According to research in recent years, it was found that 627,000 women died from breast cancer which is exactly 15% of all cancer deaths among women. Breast cancer can be caused due to smoking of tobacco, alcohol consumption, and unhealthy behavior and several other risk factors. Nearly 70% of deaths from breast cancer are seen in low and middle income countries. Project Panel has continuous update and has judged that there was strong proof that consumption of alcoholic drinks, great birth weight causes breast cancer. It is estimated that worldwide over 508000 women died due to breast cancer. Incidence rates vary greatly worldwide from 19.3per 10,000 women in eastern Africa to 89.7 per 10,000 women in Western Europe. Breast cancer survival rates vary greatly worldwide, ranging from 80% or over in North America, Sweden and Japan to around 60% in middle income countries. The low survival rates in less developed countries can be explained mainly by the lack of adequate diagnosis and treatment facilities. In America after skin cancer the most common cancer in women is breast cancer. More than 3.5millons breast cancers cases have been seen in the U.S. women and are treated still those who have finished treatment can also show cancer recurrence. Breast cancer is the top cancer in women worldwide and is increasing particularly in developing countries where the majority of cases are diagnosis and treatment facilities.
Av. Mal. Craveiro Lopes 390, 1749-009 Radisson Blu Hotel, Lisbon, Portugal